Advisory Committee

Cytokinetics Reports Second Quarter 2022 Financial Results

Retrieved on: 
Thursday, August 4, 2022 - 9:00pm

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the second quarter of 2022. Net loss for the second quarter was $19.8 million, or $0.23 per share, compared to net loss for the second quarter of 2021 of $61.6 million, or $0.86 per share. Cash, cash equivalents and investments totaled $596.7 million at June 30, 2022.

Key Points: 
  • Advisory Committee Meeting to Review NDA for Omecamtiv Mecarbil Scheduled for December 13, 2022; PDUFA Target Action Date Set for February 28, 2023
    Company Revises 2022 Financial Guidance; Reduces Projected Spending for 2022
    SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the second quarter of 2022.
  • Net loss for the second quarter was $19.8 million, or $0.23 per share, compared to net loss for the second quarter of 2021 of $61.6 million, or $0.86 per share.
  • During the second quarter we made progress across regulatory, clinical and financial objectives.
  • CYTOKINETICS and the CYTOKINETICS and C-shaped logo are registered trademarks of Cytokinetics in the U.S. and certain other countries.

Equifax® Canada Expands Financial Data Exchange Engagement

Retrieved on: 
Wednesday, August 3, 2022 - 12:00pm

TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Equifax Canada is deepening its commitment to promote a consent-based approach to open banking and educating Canadians on consumer-led banking by expanding its engagement with Financial Data Exchange.

Key Points: 
  • TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Equifax Canada is deepening its commitment to promote a consent-based approach to open banking and educating Canadians on consumer-led banking by expanding its engagement with Financial Data Exchange.
  • As a non-FI member of FDX, Equifax has a unique ability to bring the industry together given its work with both Financial Institutions and Fintechs in Canada.
  • Financial Data Exchange, LLC is a non-profit organization operating in the US and Canada that is dedicated to unifying the nancial industry around a common, interoperable, royalty-free standard for secure and convenient consumer and business access to their financial data.
  • Membership is open to financial institutions, fintech companies, financial data aggregators, consumer advocacy groups, payment networks and other industry stakeholders.

Nissin Foods (Hong Kong) Charity Fund Launches Orange Tennis Community Programme

Retrieved on: 
Wednesday, August 3, 2022 - 6:45am

HONG KONG, Aug 3, 2022 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods", and together with its subsidiaries, the "Group"; Stock code: 1475) today announced the launch of the Nissin Foods Orange Tennis Community Programme (Tai Po) by Nissin Foods (Hong Kong) Charity Fund ("Charity Fund") and The Hong Kong Tennis Association ("HKTA"), offering regular weekly trainings for young players to promote healthy living.

Key Points: 
  • HONG KONG, Aug 3, 2022 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods", and together with its subsidiaries, the "Group"; Stock code: 1475) today announced the launch of the Nissin Foods Orange Tennis Community Programme (Tai Po) by Nissin Foods (Hong Kong) Charity Fund ("Charity Fund") and The Hong Kong Tennis Association ("HKTA"), offering regular weekly trainings for young players to promote healthy living.
  • "We are delighted to launch the first initiative to be funded by the Nissin Foods Charity Fund," said Mr. Kiyotaka ANDO, Chairman of the Advisory Committee of the Charity Fund.
  • The Nissin Foods Orange Tennis Community Programme in Tai Po extends HKTA's Orange Ball Programme which is designed to provide players aged 7-10 years from disadvantaged backgrounds a second tennis experience to further their development.
  • The Nissin Foods (Hong Kong) Charity Fund ("Charity Fund") was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475).

Kilolo Kijakazi Fellowship Program Announces Two Inaugural Fellows

Retrieved on: 
Wednesday, July 27, 2022 - 4:28pm

Washington, July 27, 2022 (GLOBE NEWSWIRE) -- The National Academy of Social Insurance (Academy) and The Policy Academies are pleased to announce the selection of the inaugural Kilolo Kijakazi Fellows.

Key Points: 
  • Washington, July 27, 2022 (GLOBE NEWSWIRE) -- The National Academy of Social Insurance (Academy) and The Policy Academies are pleased to announce the selection of the inaugural Kilolo Kijakazi Fellows.
  • The Kijakazi Fellowship was established this year in honor of Kilolo Kijakazi, the Acting Commissioner of the Social Security Administration (SSA).
  • The Fellowship seeks to continue that legacy and cultivate and accelerate the careers of emerging policy scholars whose work addresses the issues to which Kilolo Kijakazi has dedicated her stellar career.
  • Felipe Juan and Keandra Davis, both of whom are PhD students, are the two inaugural Fellows.

WISeKey Appoints Nicolas Ramseier to its Advisory Committee to Assist Further in Developing and Expanding Market Penetration of WISe.ART, Sustainable NFT and FinTech Related Projects

Retrieved on: 
Wednesday, July 27, 2022 - 6:00am

WISeKey Appoints Nicolas Ramseier to its Advisory Committee to Assist Further in Developing and Expanding Market Penetration of WISe.ART, Sustainable NFT and FinTech Related Projects

Key Points: 
  • WISeKey Appoints Nicolas Ramseier to its Advisory Committee to Assist Further in Developing and Expanding Market Penetration of WISe.ART, Sustainable NFT and FinTech Related Projects
    Geneva, Switzerland July 27, 2022: WISeKey International Holding Ltd (WISeKey or the Company) (SIX: WIHN, NASDAQ: WKEY), a leading cybersecurity and IoT company, today announced the appointment of Nicolas Ramseier to its Advisory Committee.
  • Mr. Ramseier began his banking career as an investment specialist at Bank Lombard Odier where he advised on technology and sustainability-based client portfolios.
  • With his sound technical knowledge, banking skills, and a strong network in Switzerland, Mr. Ramseiers appointment to the Advisory Committee of WISeKey will support in further developing and expanding market penetration of its WISe.ART NFT platform, as well as FinTech related projects.
  • I am honored to join WISeKeys Advisory Committee and assist the Company in addressing the new challenges around sustainability, NFT technology, and DeFi.

Ionis announces that FDA accepts New Drug Application and grants Priority Review of tofersen for a rare, genetic form of ALS

Retrieved on: 
Tuesday, July 26, 2022 - 12:30pm

The application has been granted priority review and given a Prescription Drug User Fee Act action date of Jan. 25, 2023.

Key Points: 
  • The application has been granted priority review and given a Prescription Drug User Fee Act action date of Jan. 25, 2023.
  • The FDA has noted that it is currently planning to hold an Advisory Committee meeting for this application.
  • "We also want to thank Biogen for their commitment to advancing tofersen, which, if approved, will be the first treatment that targets a genetic cause of ALS."
  • Dr. Bennett added, "Acceptance of the NDA for tofersen further strengthens Ionis' platform strategy to target all forms of ALS and central nervous system disorders more broadly."

High Unmet Needs Remain in Nephrology Despite Newly Approved Treatment Options According to Latest Research from Spherix Global Insights

Retrieved on: 
Thursday, June 30, 2022 - 3:00pm

EXTON, Pa., June 30, 2022 /PRNewswire/ -- A survey of 124 US nephrologists, conducted just last week, identifies acute kidney injury (AKI), diabetic kidney disease (DKD), and polycystic kidney disease (PKD) as areas physicians would most like to see new products approved to treat patients under their care. New agents for glomerular diseases, including focal segmental glomerulonephritis (FSGS) and IgA nephropathy (IgAN) are also in high demand.

Key Points: 
  • New agents for glomerular diseases, including focal segmental glomerulonephritis (FSGS) and IgA nephropathy (IgAN) are also in high demand.
  • In prior Spherix research, following the receipt of these CRLs, many nephrologists expressed disappointment about the non-approval of the HIF-PH inhibitors, which are approved in countries outside the US, and tenapanor.
  • Korsuva, for CKD-associated pruritus in hemodialysis patients, is the newest approved renal product that Spherix is tracking.
  • Korsuva was originally approved in August of 2021; however, the product didn't officially launch until this past spring.

The Worldwide Poultry Vaccines Industry is Expected to Reach $2.8 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022 - 12:22pm

The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

Key Points: 
  • The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.
  • Rumors spread on social media about poultry birds being possible vectors of SARS-CoV-2 further hampered the demand for poultry products.
  • With the rise in demand for poultry food products, the need for vaccines is on the rise to keep poultry safe and achieve optimum yields.
  • Poultry birds are susceptible to various fowl illnesses, which cause significant economic losses to the business, particularly in poorer nations.

CIO Strategy Council enters partnership to develop Standards for Election and Voting Technologies

Retrieved on: 
Thursday, June 23, 2022 - 4:02pm

OTTAWA, June 23, 2022 (GLOBE NEWSWIRE) -- The CIO Strategy Council and the Advisory Committee on Standards for Voting Technologies are collaborating to develop Standards to guide the use of vote tabulators and electronic poll books.

Key Points: 
  • OTTAWA, June 23, 2022 (GLOBE NEWSWIRE) -- The CIO Strategy Council and the Advisory Committee on Standards for Voting Technologies are collaborating to develop Standards to guide the use of vote tabulators and electronic poll books.
  • The Chief Electoral Officer of Ontario established the Advisory Committee on Standards for Voting Technologies under amendments to Ontarios Election Act that was introduced in April 2021.
  • These Standards would advise and guide election administrators in the areas of electoral technology, evaluation of voting technologies, and deployment of voting technologies.
  • Keith Jansa, Executive Director of the CIO Strategy Council:
    It's great to partner with the Advisory Committee on Standards for Voting Technologies to help standardize electoral processes in Canada.

The Exceptional Women's Awardees (EWA) congratulates Shruti Miyashiro on next chapter

Retrieved on: 
Thursday, June 23, 2022 - 2:00pm

LOS ANGELES, June 23, 2022 /PRNewswire-PRWeb/ -- The Exceptional Women's Awardees (EWA) is proud to recognize that Shruti Miyashiro, Exceptional Awardee from Cohort 9, will be transitioning from President and CEO at Orange County's Credit Union to President and CEO at Digital Federal Credit Union (DCU), one of the largest credit unions in the nation.

Key Points: 
  • As President and CEO, Shruti worked closely with the Board of Directors and led Orange County's Credit Union for 14 years.
  • Orange County's Credit Union was regularly recognized as "Best Place to Work" and "Best in State Credit Union" by Forbes magazine with Shruti leading.
  • "We congratulate Shruti on her career advancement from President and CEO of Orange County's Credit Union to President and CEO of Digital Federal Credit Union!
  • The Exceptional Women Awardees Foundation (EWA) is an invitation only mentorship organization where high-potential, high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed.